PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.8055
-0.0367 (-4.36%)
At close: Sep 18, 2026, 4:00 PM EDT
0.8282
+0.0227 (2.82%)
After-hours: Sep 18, 2026, 7:59 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $45.08 million as of September 18, 2026. Its market cap has decreased by -16.63% in one year.
Market Cap
45.08M
Enterprise Value
43.85M
1-Year Change
-16.63%
Ranking
Category
Stock Price
$0.81
ChartMarket Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $45.08M, a decrease of -0.94%. That is a compound annual growth rate of -0.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 45.08M | 7.03% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clene | 53.32M |
| Tevogen | 50.20M |
| Apollomics | 49.47M |
| Elicio Therapeutics | 49.02M |
| Instil Bio | 48.90M |
| Immutep | 47.16M |
| Annovis Bio | 46.87M |
| Werewolf Therapeutics | 46.80M |